| Status: Excluded due to NICE appraisal | |
Product meets AWMSG exclusion criteria due to NICE appraisal TA588: Nusinersen for treating spinal muscular atrophy |
|
Medicine details |
|
| Medicine name | nusinersen (Spinraza®) |
| Formulation | 2.4 mg/ml solution for injection |
| Reference number | 3067 |
| Indication | Treatment of 5q spinal muscular atrophy |
| Company | Biogen Idec Ltd |
| BNF chapter | Musculoskeletal & joint diseases |
| Submission type | N/A |
| Status | Excluded due to NICE appraisal |
| Date of issue | 14/07/2017 |
| NICE guidance | |